Info on POTUS call with Pharmaceutical companies
Today, President Donald J. Trump spoke by telephone with executives of pharmaceutical companies to discuss the all-of-America response to COVID-19. The President acknowledged the industry’s progress in developing therapeutics to fight this pandemic and promised the Federal Government will continue to be a helpful partner with science and data leading the way. The executives thanked President Trump for directing his Administration to break down barriers, cut red tape, and encourage cooperation across all industries and Government to best meet the needs of the American people during this unprecedented time. President Trump continues to lead a whole-of-Government response to combat the health and economic effects of this invisible enemy.
External Participants
Robert Bradway, CEO, Amgen
Alexander Hardy, CEO, Genetech
Daniel O’Day, CEO, Gilead
Leonard Schleifer, CEO, Regeneron
https://publicpool.kinja.com/subject-wh-in-town-pool-report-4-pharmaceutical-comp-1842711445